Ausgabe 3/2012
Inhalt (46 Artikel)
The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005–2008
B. Dawson-Hughes, A. C. Looker, A. N. A. Tosteson, H. Johansson, J. A. Kanis, L. J. Melton III
Rib fracture as a predictor of future fractures in young and older postmenopausal women: National Osteoporosis Risk Assessment (NORA)
S. G. Sajjan, E. Barrett-Connor, C. A. McHorney, P. D. Miller, S. S. Sen, E. Siris
Comparative trends in hospitalizations for osteoporotic fractures and other frequent diseases between 2000 and 2008
K. Lippuner, S. Grifone, M. Schwenkglenks, P. Schwab, A. W. Popp, C. Senn, R. Perrelet
Measuring health-related quality of life (HRQOL) in osteoporotic males using the Male OPAQ
S. L. Solimeo, S. L. Silverman, A. D. Calderon, A. Nguyen, D. T. Gold
A comparative study of using non-hip bone density inputs with FRAX®
W. D. Leslie, L. M. Lix, H. Johansson, A. Oden, E. McCloskey, J. A. Kanis
Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures
A. Lalmohamed, P. M. J. Welsing, W. F. Lems, J. W. G. Jacobs, J. A. Kanis, H. Johansson, A. De Boer, F. De Vries
Discriminative value of FRAX for fracture prediction in a cohort of Chinese postmenopausal women
E. Y. N. Cheung, C. H. Bow, C. L. Cheung, C. Soong, S. Yeung, C. Loong, A. Kung
Ethnic difference of clinical vertebral fracture risk
C. H. Bow, E. Cheung, C. L. Cheung, S. M. Xiao, C. Loong, C. Soong, K. C. Tan, M. M. Luckey, J. A. Cauley, S. Fujiwara, A. W. C. Kung
Renal function and nonvertebral fracture risk in multiethnic women: the Women’s Health Initiative (WHI)
K. E. Ensrud, K. Barbour, M. T. Canales, M. E. Danielson, R. M. Boudreau, D. C. Bauer, A. Z. LaCroix, A. Ishani, R. D. Jackson, J. A. Robbins, J. A. Cauley
The rate of hip osteoarthritis in patients with proximal femoral fractures versus hip contusion
B. Robstad, F. Frihagen, L. Nordsletten
A comparison of case-finding strategies in the UK for the management of hip fractures
H. Johansson, J. A. Kanis, A. Oden, J. Compston, E. McCloskey
The direct cost of acute hip fracture care in care home residents in the UK
O. Sahota, N. Morgan, C. G. Moran
Estimation of the lifetime risk of hip fracture for women and men in Canada
R. B. Hopkins, E. Pullenayegum, R. Goeree, J. D. Adachi, A. Papaioannou, W. D. Leslie, J. E. Tarride, L. Thabane
The post-fracture care gap among Canadian First Nations peoples: a retrospective cohort study
W. D. Leslie, S. L. Brennan, H. J. Prior, L. M. Lix, C. Metge, B. Elias
Adiposity and bone health in Spanish adolescents. The HELENA study
L. Gracia-Marco, F. B. Ortega, D. Jiménez-Pavón, G. Rodríguez, M. J. Castillo, G. Vicente-Rodríguez, L. A. Moreno
Incidence of hip fracture and prevalence of osteoporosis in Turkey: the FRACTURK study
S. Tuzun, N. Eskiyurt, U. Akarirmak, M. Saridogan, M. Senocak, H. Johansson, J. A. Kanis
Ankle fractures do not predict osteoporotic fractures in women with or without diabetes
J. M. Pritchard, L. M. Giangregorio, G. Ioannidis, A. Papaioannou, J. D. Adachi, W. D. Leslie
Low bone mineral density is associated with increased risk for myocardial infarction in men and women
P. Wiklund, A. Nordström, J.-H. Jansson, L. Weinehall, P. Nordström
PTH level but not 25 (OH) vitamin D level predicts bone loss rates in the elderly
A. Arabi, R. Baddoura, R. El-Rassi, G. El-Hajj Fuleihan
Relationships between serum vitamin D levels, neuromuscular and neuropsychological function and falls in older men and women
J. C. Menant, J. C. T. Close, K. Delbaere, D. L. Sturnieks, J. Trollor, P. S. Sachdev, H. Brodaty, S. R. Lord
Low serum vitamin D is associated with increased mortality in elderly men: MrOS Sweden
H. Johansson, A. Odén, J. Kanis, E. McCloskey, M. Lorentzon, Ö. Ljunggren, M. K. Karlsson, P. M. Thorsby, Å. Tivesten, E. Barrett-Connor, C. Ohlsson, D. Mellström
Predictive values of calcaneal quantitative ultrasound and dual energy X ray absorptiometry for non-vertebral fracture in older men: results from the MrOS study (Hong Kong)
T. Kwok, C. C. Khoo, J. Leung, A. Kwok, L. Qin, J. Woo, P. C. Leung
Identification of prevalent vertebral fractures using CT lateral scout views: a comparison of semi-automated quantitative vertebral morphometry and radiologist semi-quantitative grading
Y. M. Kim, S. Demissie, H. K. Genant, X. Cheng, W. Yu, E. J. Samelson, D. P. Kiel, M. L. Bouxsein
Validated risk rule using computerized data to identify males at high risk for fracture
J. LaFleur, R. E. Nelson, Y. Yao, R. A. Adler, J. R. Nebeker
Association of spinal curve deformity and back extensor strength in elderly women with osteoporosis in Japan and the United States
M. Hongo, N. Miyakoshi, Y. Shimada, M. Sinaki
Prevalence of non-fracture short vertebral height is similar in premenopausal and postmenopausal women: the osteoporosis and ultrasound study
L. Ferrar, C. Roux, D. M. Reid, D. Felsenberg, C. C. Glüer, R. Eastell
Treatment for older men with fractures
A. J. Shepherd, A. R. Cass, L. A. Ray, A. Tan, G. S. Wilkinson
Adherence to osteoporosis medications amongst Singaporean patients
M. H. H. Cheen, M. C. Kong, R. F. Zhang, F. M. H. Tee, M. Chandran
Undertreatment of osteoporosis in persons with dementia? A population-based study
Y. Haasum, J. Fastbom, L. Fratiglioni, K. Johnell
Impact of bone turnover markers and/or educational information on persistence to oral bisphosphonate therapy: a community setting-based trial
S. L. Silverman, K. Nasser, S. Nattrass, B. Drinkwater
Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada
A. M. Burden, J. M. Paterson, D. H. Solomon, M. Mamdani, D. N. Juurlink, S. M. Cadarette
Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis
C. Roux, D. M. Reid, J.-P. Devogelaer, K. Saag, C. S. Lau, J.-Y. Reginster, P. Papanastasiou, C. Bucci-Rechtweg, G. Su, P. N. Sambrook
Arzoxifene versus raloxifene: effect on bone and safety parameters in postmenopausal women with osteoporosis
D. L. Kendler, S. Palacios, D. A. Cox, J. Stock, J. Alam, S. A. Dowsett, J. Zanchetta
The impact of teriparatide adherence and persistence on fracture outcomes
S. Yu, R. T. Burge, S. A. Foster, S. Gelwicks, E. S. Meadows
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis
J-Y. Reginster, J-M. Kaufman, S. Goemaere, J. P. Devogelaer, C. L. Benhamou, D. Felsenberg, M. Diaz-Curiel, M-L. Brandi, J. Badurski, J. Wark, A. Balogh, O. Bruyère, C. Roux
Sclerostin levels during growth in children
S. Kirmani, S. Amin, L. K. McCready, E. J. Atkinson, L. Joseph Melton III, R. Müller, S. Khosla
Dose–response study of denosumab on bone mineral density and bone turnover markers in Japanese postmenopausal women with osteoporosis
T. Nakamura, T. Matsumoto, T. Sugimoto, M. Shiraki
Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta
R. Bargman, R. Posham, A. L. Boskey, E. DiCarlo, C. Raggio, N. Pleshko
Premature T cell senescence in Ovx mice is inhibited by repletion of estrogen and medicarpin: a possible mechanism for alleviating bone loss
A. M. Tyagi, K. Srivastava, J. Kureel, A. Kumar, A. Raghuvanshi, D. Yadav, R. Maurya, A. Goel, D. Singh
UGT2B17 gene deletion associated with an increase in bone mineral density similar to the effect of hormone replacement in postmenopausal women
S. Giroux, J. Bussières, A. Bureau, F. Rousseau
Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women—the six-month effect of risedronate and teriparatide
S. A. Polyzos, A. D. Anastasilakis, C. Bratengeier, W. Woloszczuk, A. Papatheodorou, E. Terpos
Low calcidiol levels and risk of progression of aortic calcification
M. Naves-Díaz, I. Cabezas-Rodríguez, S. Barrio-Vázquez, E. Fernández, J. B. Díaz-López, J. B. Cannata-Andía
Strontium uptake and effects in bone: reply to Fogelman and Blake
P. J. Marie, D. Felsenberg, M-L. Brandi